ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1681–1692 of 2020 project topics
BMPR2 Hereditary PAH Molecular Testing
Developing comprehensive BMPR2 sequencing and MLPA for diagnosing hereditary PAH and counseling asymptomatic variant carriers on surveillance.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Non-BMPR2 PAH Gene Panel Testing
Testing ACVRL1, ENG, SMAD9, CAV1, KCNK3, and ATP13A3 genes in BMPR2-negative PAH for identifying causative variants in heritable disease.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
EIF2AK4 Pulmonary Veno-Occlusive Disease Testing
Characterizing biallelic EIF2AK4 variants causing pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis for molecular diagnosis.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
PAH Gene-Treatment Response Correlation Studies
Investigating whether causative gene variants in PAH predict response to pulmonary vasodilators for developing genotype-guided treatment algorithms.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
AI-Powered PAH Genetic Risk Stratification SaaS Platform
A cloud-based machine learning platform that analyzes whole exome sequencing data to predict PAH disease severity and progression risk in individual patients. This enables precision medicine workflows and recurring subscription revenue through clinical laboratory partnerships and healthcare systems.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Multi-Gene PAH Variant Classification and Interpretation Tool
A proprietary bioinformatics software that automatically classifies rare variants across 15+ PAH-associated genes using integrated databases and evidence-based scoring algorithms. This tool reduces manual curation time for diagnostic labs and creates licensing opportunities with clinical genomics providers.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Real-Time PAH Genetic Data Registry and Analytics Dashboard
An enterprise analytics platform that aggregates de-identified PAH genetic data from multiple clinical sites to enable population-level genotype-phenotype correlations and drug response tracking. Revenue streams include data licensing to pharmaceutical companies and institutional subscription fees.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Genetic Counseling Support Tool for PAH Patient Families
A digital platform that generates personalized genetic risk reports and family cascade screening recommendations for hereditary PAH carriers with interactive education modules. This creates B2B revenue through healthcare provider licensing and direct-to-consumer telemedicine integration fees.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Pharmacogenomic-PAH Gene Interaction Prediction Engine
A computational platform that models drug metabolism and treatment response based on individual PAH genetic profiles and pharmacogenetic markers to optimize therapeutic selection. This drives revenue through partnerships with PAH pharmaceutical manufacturers and clinical trial matching services.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
Next-Generation PAH Genetic Biomarker Discovery Service
A comprehensive genomic analysis service that identifies novel PAH-associated mutations and epigenetic biomarkers through whole genome sequencing and RNA profiling of patient cohorts. This creates revenue through research contracts with biotech companies and diagnostic marker licensing agreements.
Genetic Basis of Pulmonary Arterial Hypertension Click to view more details →
ABCC8 and KCNJ11 Hyperinsulinism Testing
Developing comprehensive KATP channel gene testing for focal versus diffuse hyperinsulinism distinction and directing surgical versus medical management.
Genetic Basis of Hyperinsulinism Click to view more details →
GCK Activating Mutation Hyperinsulinism
Identifying GCK activating mutations in patients with mild persistent hypoglycemia for distinguishing from KATP channel mutations with different management.
Genetic Basis of Hyperinsulinism Click to view more details →